Rituximab administration in third trimester of pregnancy suppresses neonatal B-cell development (Q33380175)

26 July 2017

0 references

Rituximab administration in third trimester of pregnancy suppresses neonatal B-cell development (English)

1 reference

26 July 2017

1 reference

D T Klink

1

1 reference

26 July 2017

R M van Elburg

series ordinal

2

1 reference

26 July 2017

M W J Schreurs

series ordinal

3

1 reference

26 July 2017

G T J van Well

series ordinal

4

1 reference

26 July 2017

1 January 2008

1 reference

Clinical and Developmental Immunology

26 July 2017

1 reference

26 July 2017

2008

1 reference

26 July 2017

271363

1 reference

Creative Commons Attribution 3.0 Unported

26 July 2017

start time

1 January 2008

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438602

Targeted ITP strategies: do they elucidate the biology of ITP and related disorders?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438602

Successful management of pregnancy in women with a history of thrombotic thrombocytopaenic purpura

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438602

Ex vivo-activated human macrophages kill chronic lymphocytic leukemia cells in the presence of rituximab: mechanism of antibody-dependent cellular cytotoxicity and impact of human serum.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438602

Clinical and immunological effects of Rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438602

Antirheumatic drugs in pregnancy and lactation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438602

Platelets: an update on diagnosis and management of thrombocytopenic disorders.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438602

Splenectomy-sparing strategies for the treatment and long-term maintenance of chronic idiopathic (immune) thrombocytopenic purpura

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438602

Overview of the clinical development of rituximab: first monoclonal antibody approved for the treatment of lymphoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438602

Dynamics of immunoglobulins at the feto-maternal interface

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438602

Guidelines on the investigation and management of thrombocytopenia in pregnancy and neonatal alloimmune thrombocytopenia. Maternal and Neonatal Haemostasis Working Party of the Haemostasis and Thrombosis Task Force of the British Society for Haemato

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438602

Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438602

Neonatal pancytopenia and severe combined immunodeficiency associated with antenatal administration of azathioprine and prednisone

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438602

Intrauterine growth of live-born Caucasian infants at sea level: standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks of gestation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438602

Estimation of the risk of thrombocytopenia in the offspring of pregnant women with presumed immune thrombocytopenic purpura

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438602

6-Thioguanine for Crohn's disease during pregnancy: thiopurine metabolite measurements in both mother and child

21 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2F2008%2F271363

Safety of rituximab therapy during the first trimester of pregnancy: a case history

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2F2008%2F271363

Biologic response of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complement-mediated cell lysis.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438602

Administration of rituximab during the first trimester of pregnancy without consequences for the newborn

31 October 2018

1 reference

12 December 2020

Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy

1 reference

12 December 2020

[Multi-drug resistance in the treatments of autoimmune diseases]

1 reference

12 December 2020

The effects of rituximab treatment during pregnancy on a neonate

1 reference

12 December 2020

Intrauterine growth and intrauterine growth curves

1 reference

12 December 2020

Identifiers

DOI

10.1155/2008/271363

1 reference

26 July 2017

1 reference

26 July 2017

1 reference